• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    ContextLogic Inc. - Class A Common Stock (NQ:LOGC)

    7.090 -0.030 (-0.42%)
    Streaming Delayed Price Updated: 11:43 AM EDT, Apr 29, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about ContextLogic Inc. - Class A Common Stock

    ContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial Results
    From ContextLogic Inc.
    Via GlobeNewswire
    ContextLogic to Announce Fourth Quarter and Full Year 2024 Results and Provide Strategic Update on March 12, 2025
    From ContextLogic Inc.
    Via GlobeNewswire
    ContextLogic Announces Up to $150 Million Strategic Investment by BC Partners
    From ContextLogic Inc.
    Via GlobeNewswire
    ContextLogic Inc. Reports Third-Quarter 2024 Financial Results
    From ContextLogic Inc.
    Via GlobeNewswire
    ContextLogic Inc. Reports Second-Quarter Financial Results
    From ContextLogic Inc.
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) Myovant Sciences Ltd. (NYSE - MYOV), ForgeRock, Inc. (NYSE - FORG), SeaSpine Holdings Corporation (Nasdaq - SPNE), LogicBio Therapeutics, Inc. (Nasdaq – LOGC),
    From Brodsky & Smith LLC
    Via GlobeNewswire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) ForgeRock, Inc. (NYSE - FORG), SeaSpine Holdings Corporation (Nasdaq - SPNE), LogicBio Therapeutics, Inc. (Nasdaq – LOGC), Coffee Holding Co., Inc. (Nasdaq – JVA)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    LOGICBIO® THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LogicBio® Therapeutics, Inc. - LOGC
    From Kahn Swick & Foti, LLC
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) CarLotz, Inc. (Nasdaq – LOTZ), LogicBio Therapeutics, Inc. (Nasdaq – LOGC), O2Micro International Limited (Nasdaq – OIIM), Coffee Holding Co., Inc. (Nasdaq – JVA)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    LOGICBIO® THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LogicBio® Therapeutics, Inc. - LOGC
    From Kahn Swick & Foti, LLC
    Via Business Wire
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations:) LogicBio Therapeutics, Inc. (Nasdaq – LOGC), O2Micro International Limited (Nasdaq – OIIM), Coffee Holding Co., Inc. (Nasdaq – JVA), BTRS Holdings Inc. (Nasdaq –
    From Brodsky & Smith LLC
    Via GlobeNewswire
    LOGC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LogicBio Therapeutics, Inc. Is Fair to Shareholders
    From Halper Sadeh LLC
    Via Business Wire
    Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic Medicine
    From Alexion
    Via Business Wire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.